These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
553 related items for PubMed ID: 33130468
1. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity. Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J, Huang W. Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468 [Abstract] [Full Text] [Related]
2. Impact of blood-brain barrier disruption on clinical features and treatment response in patients with newly diagnosed autoimmune encephalitis. Cheng X, Li Y, Wang Y, Sun Y, Lian Y. J Neuroimmunol; 2023 Oct 15; 383():578203. PubMed ID: 37740995 [Abstract] [Full Text] [Related]
3. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis. Wu Q, Xie Q, Liu L, Meng C, Wang J. Mult Scler Relat Disord; 2023 Jun 15; 74():104697. PubMed ID: 37031550 [Abstract] [Full Text] [Related]
4. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children]. Wang GL, Yin F, Wang Y, Zhang WX, He F, Yang LF, Wu LW, Peng J. Zhonghua Er Ke Za Zhi; 2019 Feb 02; 57(2):125-130. PubMed ID: 30695887 [Abstract] [Full Text] [Related]
13. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis. Hümmert MW, Jendretzky KF, Fricke K, Gingele M, Ratuszny D, Möhn N, Trebst C, Skripuletz T, Gingele S, Sühs KW. Sci Rep; 2023 Aug 04; 13(1):12696. PubMed ID: 37542085 [Abstract] [Full Text] [Related]
14. Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness. Gong Z, Lao D, Huang F, Lv S, Mao F, Huang W. Patient Relat Outcome Meas; 2023 Aug 04; 14():181-192. PubMed ID: 37337520 [Abstract] [Full Text] [Related]
15. [Disease Characteristics, Treatment, and Prognosis of Chinese Patients with Autoimmune Encephalitis: A Retrospective Study]. Yang RN, Ge FF, Jiang JW, Wang Y, Zhang W. Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan 04; 53(1):142-148. PubMed ID: 35048615 [Abstract] [Full Text] [Related]
16. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study. Zeng W, Cao L, Zheng J, Yu L. Neurol Sci; 2021 Jan 04; 42(1):199-207. PubMed ID: 32601745 [Abstract] [Full Text] [Related]
17. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis. Li J, Gu Y, An H, Zhou Z, Zheng D, Wang Z, Wen Z, Shen HY, Wang Q, Wang H. Brain Behav; 2019 Aug 04; 9(8):e01354. PubMed ID: 31313506 [Abstract] [Full Text] [Related]
19. Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis. Yan L, Zhang S, Huang X, Tang Y, Wu J. Front Neurol; 2021 Aug 04; 12():609750. PubMed ID: 33613429 [Abstract] [Full Text] [Related]
20. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis. Zhang M, Li W, Zhou S, Zhou Y, Yang H, Yu L, Wang J, Wang Y, Zhang L. Front Neurol; 2019 Aug 04; 10():596. PubMed ID: 31244759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]